Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy. [electronic resource]
Producer: 20120716Description: 4686-97 p. digitalISSN:- 1528-0020
- Biological Availability
- Cell Line, Tumor
- Cell Proliferation
- Cell Survival -- genetics
- Cells, Cultured
- Disease Progression
- Drug Evaluation, Preclinical
- Gene Expression Regulation, Neoplastic -- drug effects
- Glucose -- metabolism
- Glucose Transport Proteins, Facilitative -- antagonists & inhibitors
- Glucose Transporter Type 4 -- antagonists & inhibitors
- HIV Protease Inhibitors -- pharmacology
- Humans
- Molecular Targeted Therapy -- methods
- Multiple Myeloma -- genetics
- Off-Label Use
- Primary Cell Culture
- Ritonavir -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.